Table 1 Sample size requirements at Levels 2 and 3, based on adding variability to each individual dose–response curve parameter.
Sample size (n) | |||||
|---|---|---|---|---|---|
Theoretical | Slope | EC50 | MaxResp | MinResp | |
Level 2 | |||||
Group mean difference = 0.01 | |||||
Variability | |||||
0.0 | 1571 | 1643 (1.05x) | 1636 (1.04x) | 1657 (1.05x) | 1658 (1.06x) |
0.1 | 1571 | 1666 (1.06x) | 3467 (2.21x) | 2016 (1.28x) | 2103 (1.28x) |
0.5 | 1571 | 2298 (1.46x) | > 10,000 (6.37x) | > 10,000 (6.37x) | > 10,000 (6.37x) |
1.0 | 1571 | 5743 (3.66x) | > 10,000 (6.37x) | > 10,000 (6.37x) | > 10,000 (6.37x) |
Group mean difference = 0.11 | |||||
Variability | |||||
0.0 | 15 | 15 (1.00x) | 15 (1.00x) | 15 (1.00x) | 15 (1.00x) |
0.1 | 15 | 16 (1.07x) | 35 (2.33x) | 20 (1.33x) | 19 (1.27x) |
0.5 | 15 | 22 (1.47x) | 679 (45x) | 163 (11x) | 118 (7.87x) |
1.0 | 15 | 66 (4.40x) | 3313 (221x) | 885 (59x) | 692 (46x) |
Level 3 | |||||
Group mean difference = 0.01 | |||||
Variability | |||||
0.0 | 1571 | 1708 (1.09x) | 1708 (1.09x) | 1714 (1.09x) | 1714 (1.09x) |
0.1 | 1571 | 1741 (1.11x) | 4117 (2.62x) | 2181 (1.39x) | 2331 (1.48x) |
0.5 | 1571 | 2652 (1.69x) | > 10,000 (6.37x) | > 10,000 (6.37x) | > 10,000 (6.37x) |
1.0 | 1571 | > 10,000 (6.37x) | > 10,000 (6.37x) | > 10,000 (6.367x) | > 10,000 (6.37x) |
Group mean difference = 0.11 | |||||
Variability | |||||
0.0 | 15 | 16 (1.07x) | 16 (1.07x) | 16 (1.07x) | 16 (1.07x) |
0.1 | 15 | 17 (1.13x) | 43 (2.87x) | 23 (1.53x) | 22 (1.47x) |
0.5 | 15 | 26 (1.73x) | 1108 (74x) | 267 (18x) | 233 (16x) |
1.0 | 15 | 135 (9.00x) | 3456 (230x) | 2159 (144x) | 2916 (194x) |